AYTU BIOPHARMA, INC Cash, Period Increase (Decrease)
AYTU BIOPHARMA, INC (AYTU) reported Cash, Period Increase (Decrease) of -$2.21 thousand for the 6-month period ending 2015-02-28, per its 10-Q filed 2015-04-15.
Discontinued › Notes
us-gaap:CashPeriodIncreaseDecrease · last filed 2015-04-15
- AYTU BIOPHARMA, INC cash, period increase (decrease) for the quarter ending 2015-02-28 was -$8.90K.
- AYTU BIOPHARMA, INC cash, period increase (decrease) for the quarter ending 2014-11-30 was $6.68K.
- AYTU BIOPHARMA, INC cash, period increase (decrease) for the quarter ending 2014-05-31 was $8.79K.
- AYTU BIOPHARMA, INC cash, period increase (decrease) for the quarter ending 2014-02-28 was -$261.00, a 110.50% decline year-over-year.
- AYTU BIOPHARMA, INC cash, period increase (decrease) for fiscal 2013 was $1.75K.
- AYTU BIOPHARMA, INC cash, period increase (decrease) for fiscal 2012 was -$3.88K, a 258.66% decline from fiscal 2011.
- AYTU BIOPHARMA, INC cash, period increase (decrease) for fiscal 2011 was $2.45K.
| Period end | Cash, Period Increase (Decrease) 3 month | Cash, Period Increase (Decrease) 6 month | Cash, Period Increase (Decrease) 9 month | Cash, Period Increase (Decrease) 12 month | Cash, Period Increase (Decrease) 81 month | Cash, Period Increase (Decrease) 84 month | Cash, Period Increase (Decrease) 87 month | Cash, Period Increase (Decrease) 90 month | Cash, Period Increase (Decrease) 93 month | Cash, Period Increase (Decrease) 96 month | Cash, Period Increase (Decrease) 99 month | Cash, Period Increase (Decrease) 102 month | Cash, Period Increase (Decrease) 105 month | Cash, Period Increase (Decrease) 108 month | Cash, Period Increase (Decrease) 111 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-02-28 | -$8.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-04-15 | -$2.21K 10-Q · filed 2015-04-15 | |||||||||||||
| 2014-11-30 | $6.68K 10-Q · filed 2015-01-12 | ||||||||||||||
| 2014-05-31 | $8.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-07-10 | $8.52K derived: sum of 2 quarters · filed 2015-04-15 | $7.11K 10-Q · filed 2014-07-10 | $8.24K derived: sum of 4 quarters · filed 2015-04-15 | $8.87K 10-Q · filed 2014-07-10 | ||||||||||
| 2014-02-28 | -$261.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-04-15 | -$1.68K 10-Q · filed 2015-04-15 | -$544.00 derived: sum of 3 quarters · filed 2015-04-15 | -$3.00K derived: sum of 4 quarters · filed 2015-04-15 | $84.00 10-Q · filed 2014-04-11 | ||||||||||
| 2013-11-30 | -$1.42K 10-Q · filed 2015-01-12 | -$283.00 derived: sum of 2 quarters · filed 2015-01-12 | -$2.74K derived: sum of 3 quarters · filed 2015-01-12 | -$256.00 derived: sum of 4 quarters · filed 2015-01-12 | $345.00 10-Q · filed 2014-01-10 | ||||||||||
| 2013-08-31 | $1.13K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-26 | -$1.32K derived: sum of 2 quarters · filed 2014-11-26 | $1.16K derived: sum of 3 quarters · filed 2014-11-26 | $1.75K 10-K · filed 2014-11-26 | $1.76K 10-K · filed 2014-11-26 | ||||||||||
| 2013-05-31 | -$2.46K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-07-10 | $27.00 derived: sum of 2 quarters · filed 2014-07-10 | $619.00 10-Q · filed 2014-07-10 | $680.00 derived: sum of 4 quarters · filed 2014-11-26 | $628.00 10-Q · filed 2013-06-28 | ||||||||||
| 2013-02-28 | $2.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-04-11 | $3.08K 10-Q · filed 2014-04-11 | $3.14K derived: sum of 3 quarters · filed 2014-11-26 | $2.34K derived: sum of 4 quarters · filed 2014-11-26 | $3.09K 10-Q · filed 2013-04-15 | ||||||||||
| 2012-11-30 | $592.00 10-Q · filed 2014-01-10 | $653.00 derived: sum of 2 quarters · filed 2014-11-26 | -$147.00 derived: sum of 3 quarters · filed 2014-11-26 | -$1.02K derived: sum of 4 quarters · filed 2014-11-26 | $601.00 10-Q · filed 2013-01-14 | ||||||||||
| 2012-08-31 | $61.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-26 | -$739.00 derived: sum of 2 quarters · filed 2014-11-26 | -$1.61K derived: sum of 3 quarters · filed 2014-11-26 | -$3.88K 10-K · filed 2014-11-26 | $9.00 10-K · filed 2012-11-29 | ||||||||||
| 2012-05-31 | -$800.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-06-28 | -$1.67K derived: sum of 2 quarters · filed 2013-06-28 | -$3.94K 10-Q · filed 2013-06-28 | -$6.96K derived: sum of 4 quarters · filed 2013-06-28 | -$52.00 10-Q · filed 2012-06-26 | ||||||||||
| 2012-02-29 | -$869.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-04-15 | -$3.15K 10-Q · filed 2013-04-15 | -$6.16K derived: sum of 3 quarters · filed 2013-04-15 | -$5.42K derived: sum of 4 quarters · filed 2013-04-15 | $748.00 10-Q · filed 2012-04-12 | ||||||||||
| 2011-11-30 | -$2.28K 10-Q · filed 2013-01-14 | -$5.29K derived: sum of 2 quarters · filed 2013-01-14 | -$4.55K derived: sum of 3 quarters · filed 2013-01-14 | $806.00 derived: sum of 4 quarters · filed 2013-01-14 | $1.62K 10-Q · filed 2011-12-23 | ||||||||||
| 2011-08-31 | -$3.02K derived: 10-K 12 month − 10-Q 9 month · filed 2012-11-29 | -$2.28K derived: sum of 2 quarters · filed 2012-11-29 | $3.08K derived: sum of 3 quarters · filed 2012-11-29 | $2.45K 10-K · filed 2012-11-29 | |||||||||||
| 2011-05-31 | $741.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-06-26 | $6.10K derived: sum of 2 quarters · filed 2012-06-26 | $5.47K 10-Q · filed 2012-06-26 | ||||||||||||
| 2011-02-28 | $5.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-04-12 | $4.72K 10-Q · filed 2012-04-12 | |||||||||||||
| 2010-11-30 | -$634.00 10-Q · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |